-
3
pages
-
English
-
Documents
-
2013
Description
Kymab Defends Patent Action in UKKymab Defends Patent Action in UK PR Newswire CAMBRIDGE, England, October 9, 2013 Kymab, a monoclonal antibody biopharmaceutical company, announces today it has notified the
-
Publié par
-
Publié le
09 octobre 2013
-
Langue
English